Consistently, our data were consolidated by previous findings showing tenascin family as a pan-cancer stromal biomarker and negative prognosticator that promotes cell proliferation, metastasis, angiogenesis, and epithelial–mesenchymal transition72,73. Here, TNC is linked to cancer.